Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Capital Medical Associates, PC
328
mi
from 43215
Washington,
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Capital Medical Associates, PC
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Gary Richmond, MD, PA
972
mi
from 43215
Fort Lauderdale, FL
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Gary Richmond, MD, PA
972
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Wohlfeiler, Piperato and Associates, LLC
993
mi
from 43215
Miami Beach, FL
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Wohlfeiler, Piperato and Associates, LLC
993
mi
from 43215
Miami Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
ValuehealthMD, LLC
795
mi
from 43215
Orlando, FL
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
ValuehealthMD, LLC
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
St Joseph's Comprehensive Research Institute
828
mi
from 43215
Tampa, FL
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
St Joseph's Comprehensive Research Institute
828
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
AIDS Research Consortium of Atlanta
434
mi
from 43215
Atlanta, GA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
AIDS Research Consortium of Atlanta
434
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Infectious Disease Specialists of Atlanta (IDSA)
433
mi
from 43215
Decatur, GA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Infectious Disease Specialists of Atlanta (IDSA)
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Northstar Medical Center
277
mi
from 43215
Chicago, IL
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Northstar Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Chase Brexton Health Services
344
mi
from 43215
Baltimore, MD
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Chase Brexton Health Services
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Be Well Medical Center
175
mi
from 43215
Berkley, MI
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Be Well Medical Center
175
mi
from 43215
Berkley, MI
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Central West Healthcare
397
mi
from 43215
St. Louis, MO
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Central West Healthcare
397
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Southampton Healthcare
399
mi
from 43215
St. Louis, MO
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Southampton Healthcare
399
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Saint Michael's Medical Center
468
mi
from 43215
Newark, NJ
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Saint Michael's Medical Center
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Southwest CARE Center
1284
mi
from 43215
Santa Fe, NM
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Southwest CARE Center
1284
mi
from 43215
Santa Fe, NM
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Rosedale Infectious Diseases
336
mi
from 43215
Huntersville, NC
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Rosedale Infectious Diseases
336
mi
from 43215
Huntersville, NC
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Nicholaos Bellos, MD, PA
910
mi
from 43215
Dallas, TX
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Nicholaos Bellos, MD, PA
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
AIDS Arms, Inc./ Peabody Health Center
910
mi
from 43215
Dallas, TX
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
AIDS Arms, Inc./ Peabody Health Center
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Gordon E. Crofoot MD PA
994
mi
from 43215
Houston, TX
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Gordon E. Crofoot MD PA
994
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
Therapeutic Concepts, P.A.
993
mi
from 43215
Houston, TX
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
Therapeutic Concepts, P.A.
993
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated:  1/15/2016
TribalMed
2006
mi
from 43215
Seattle, WA
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
A Phase 2, Randomized, Double-Blinded Study of the Safety and Efficacy of GS-9350-boosted Atazanavir (ATV/GS-9350) Compared to Ritonavir-boosted Atazanavir (ATV/r) in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Status: Enrolling
Updated: 1/15/2016
TribalMed
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
An Open-Label Pilot Phase 2 Study to Investigate Efficacy, Safety, and Intratumoral Kinetics of ALDOXORUBICIN in HIV-Infected Patients With Kaposi's Sarcoma
Status: Enrolling
Updated:  1/19/2016
Louisiana State University Health Science Center
798
mi
from 43215
New Orleans, LA
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
An Open-Label Pilot Phase 2 Study to Investigate Efficacy, Safety, and Intratumoral Kinetics of ALDOXORUBICIN in HIV-Infected Patients With Kaposi's Sarcoma
Status: Enrolling
Updated: 1/19/2016
Louisiana State University Health Science Center
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated:  1/19/2016
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated: 1/19/2016
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated:  1/19/2016
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated: 1/19/2016
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated:  1/19/2016
Bronx Lebanon Hospital Center
483
mi
from 43215
Bronx, NY
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated: 1/19/2016
Bronx Lebanon Hospital Center
483
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated:  1/19/2016
Bronx Municipal Hosp Ctr/Jacobi Med Ctr
486
mi
from 43215
Bronx, NY
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated: 1/19/2016
Bronx Municipal Hosp Ctr/Jacobi Med Ctr
486
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated:  1/19/2016
New York Hosp - Cornell / Program for Children with AIDS
480
mi
from 43215
New York, NY
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated: 1/19/2016
New York Hosp - Cornell / Program for Children with AIDS
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated:  1/19/2016
Mount Sinai Hosp
527
mi
from 43215
New York, NY
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated: 1/19/2016
Mount Sinai Hosp
527
mi
from 43215
New York, NY
Click here to add this to my saved trials
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated:  1/19/2016
Children's Hospital of The King's Daughters
422
mi
from 43215
Norfolk, VA
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
A Phase I/II Pharmacokinetic and Safety Study of T-20 in Combination With an Optimized Background in HIV Infected Children and Adolescents
Status: Enrolling
Updated: 1/19/2016
Children's Hospital of The King's Daughters
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Pre-Exposure Prophylaxis (PrEP) Initiation and Adherence Among Black Men Who Have Sex With Men (BMSM) in Three U.S. Cities
Status: Enrolling
Updated:  1/20/2016
UCLA Vine Street Clinic
1972
mi
from 43215
Los Angeles, CA
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Pre-Exposure Prophylaxis (PrEP) Initiation and Adherence Among Black Men Who Have Sex With Men (BMSM) in Three U.S. Cities
Status: Enrolling
Updated: 1/20/2016
UCLA Vine Street Clinic
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Pre-Exposure Prophylaxis (PrEP) Initiation and Adherence Among Black Men Who Have Sex With Men (BMSM) in Three U.S. Cities
Status: Enrolling
Updated:  1/20/2016
George Washington University CRS
328
mi
from 43215
Washington,
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Pre-Exposure Prophylaxis (PrEP) Initiation and Adherence Among Black Men Who Have Sex With Men (BMSM) in Three U.S. Cities
Status: Enrolling
Updated: 1/20/2016
George Washington University CRS
328
mi
from 43215
Washington,
Click here to add this to my saved trials
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Pre-Exposure Prophylaxis (PrEP) Initiation and Adherence Among Black Men Who Have Sex With Men (BMSM) in Three U.S. Cities
Status: Enrolling
Updated:  1/20/2016
UNC CRS
353
mi
from 43215
Chapel Hill, NC
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Pre-Exposure Prophylaxis (PrEP) Initiation and Adherence Among Black Men Who Have Sex With Men (BMSM) in Three U.S. Cities
Status: Enrolling
Updated: 1/20/2016
UNC CRS
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
George Washington University
328
mi
from 43215
Washington,
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
George Washington University
328
mi
from 43215
Washington,
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
Ponce de Leon Center
434
mi
from 43215
Atlanta, GA
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
Ponce de Leon Center
434
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
The Hope Clinic of the Emory Vaccine Center
433
mi
from 43215
Decatur, GA
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
The Hope Clinic of the Emory Vaccine Center
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
Johns Hopkins Adult AIDS CRS
345
mi
from 43215
Baltimore, MD
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
Johns Hopkins Adult AIDS CRS
345
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
New Jersey Medical School- Adult Clinical Research Ctr. CRS
468
mi
from 43215
Newark, NJ
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
New Jersey Medical School- Adult Clinical Research Ctr. CRS
468
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
Bronx-Lebanon Hospital Center Clinical Research Site
482
mi
from 43215
Bronx, NY
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
Bronx-Lebanon Hospital Center Clinical Research Site
482
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
Harlem Prevention Ctr. CRS
442
mi
from 43215
New York, NY
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
Harlem Prevention Ctr. CRS
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
Unc Aids Crs
354
mi
from 43215
Chapel Hill, NC
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
Unc Aids Crs
354
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated:  1/20/2016
Wake County Health and Human Services
375
mi
from 43215
Raleigh, NC
The Women's HIV SeroIncidence Study (ISIS)
The Women's HIV SeroIncidence Study (ISIS)
Status: Enrolling
Updated: 1/20/2016
Wake County Health and Human Services
375
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
A Double-Blind, Randomized, Placebo-Controlled, Continuation Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 With and Without Ritonavir, and to Evaluate Different Formulations of GSK2838232, in Healthy Subjects
Status: Enrolling
Updated:  1/21/2016
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
A Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
A Double-Blind, Randomized, Placebo-Controlled, Continuation Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 With and Without Ritonavir, and to Evaluate Different Formulations of GSK2838232, in Healthy Subjects
Status: Enrolling
Updated: 1/21/2016
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
Status: Enrolling
Updated:  1/25/2016
Fenway Health
643
mi
from 43215
Boston, MA
Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
Status: Enrolling
Updated: 1/25/2016
Fenway Health
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Addressing Discrimination and Mistrust Among Black Men: Phase III
Addressing Discrimination and Mistrust Among Black Men: Phase III
Status: Enrolling
Updated:  1/26/2016
Fenway Health
643
mi
from 43215
Boston, MA
Addressing Discrimination and Mistrust Among Black Men: Phase III
Addressing Discrimination and Mistrust Among Black Men: Phase III
Status: Enrolling
Updated: 1/26/2016
Fenway Health
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Comparison of Tenofovir Vaginal Gel and Film Formulations
Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Tenofovir Vaginal Gel and Film Formulation
Status: Enrolling
Updated:  1/27/2016
The Johns Hopkins University School of Medicine Division of Clinical Pharmacology
342
mi
from 43215
Baltimore, MD
Comparison of Tenofovir Vaginal Gel and Film Formulations
Comparison of the Pharmacokinetics and Pharmacodynamics of Single Dose Tenofovir Vaginal Gel and Film Formulation
Status: Enrolling
Updated: 1/27/2016
The Johns Hopkins University School of Medicine Division of Clinical Pharmacology
342
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
A Double Blind, Placebo Controlled, Single and Repeat Dose Escalation Study of GSK2838232 With and Without Ritonavir for 8-11 Days in Healthy Subjects
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
A Repeat Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy Subjects
A Double Blind, Placebo Controlled, Single and Repeat Dose Escalation Study of GSK2838232 With and Without Ritonavir for 8-11 Days in Healthy Subjects
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
1982
mi
from 43215
Bakersfield, CA
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
1982
mi
from 43215
Bakersfield, CA
Click here to add this to my saved trials
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
1979
mi
from 43215
Beverly Hills, CA
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
1976
mi
from 43215
Long Beach, CA
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
1976
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated:  1/28/2016
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
201147: a Phase IIIb, Randomized, Open-label Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen Compared With Continuation of the Current Antiretroviral Regimen in HIV-1 Infected Adults Who Are Virologically Suppressed, The STRIIVING Study.
Status: Enrolling
Updated: 1/28/2016
GSK Investigational Site
1983
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials